Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Dorui Pharmaceutical (301075.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Six research reports released the rating of Dorui Pharmaceutical (sz301075), and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Tibet Dorui Pharmaceutical Co., Ltd

      Main business:

      R&D, production and sales of chemical preparations and their APIs.

      Telephone: 027-83868180

      Fax: 0895-4892099

      Date of establishment: 2016-12-22

      Listing date: 2021-09-29

      Legal representative: Deng Yong

      general manager: Deng Yong

      Registered capital: 80 million yuan

      Issue price: 27.270 yuan

      Latest total share capital: 80 million shares

      Latest outstanding shares: 10000 shares

      Segment: Shenzhen A-share Shanghai and Shenzhen A-share GEM Shenzhen Composite Index Pharmaceutical Biology Chemical pharmacy Pharmaceutical Biology Chemicals Small disk Margin trading Concept of multiple births traditional Chinese medicine

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share -0.0317 yuan 0.2356 yuan RMB 0.2414 0.1796 yuan -0.0302 yuan
      net asset value per share 9.3693 yuan 9.6508 yuan 9.7333 yuan 9.6715 yuan 9.4626 yuan
      Net operating cash flow per share -0.1615 yuan 0.1552 yuan 0.3021 yuan 0.0261 yuan 0.2209 yuan
      Return on net assets -0.34% 2.44% 2.48% 1.86% -0.32%
      Undistributed profit per share 1.9922 yuan RMB 2.0239 2.0808 yuan 2.0190 yuan 1.8101 yuan
      Capital reserve per share 6.3639 yuan 6.3652 yuan 6.3688 yuan 6.3688 yuan 6.3688 yuan
      Date of announcement Allocation scheme
      2024-05-24 RMB 1.25 for 10 pies
      2022-04-19 RMB 6.25 for 10 pies
      2024-03
      2024-02
      2023-12
      Name of shareholders Shareholding (%) Increase or decrease
      Jiaxing Qiuyang Equity Investment Co., Ltd eleven point six nine three Unchanged
      UBS AG zero point nine eight three New progress
      BARCLA ... zero point six six two New progress
      Pang Jianwei zero point six five four New progress
      GF Securities Co., Ltd zero point six four two New progress
      Li Zhengui zero point five eight nine New progress
      Kong Weidong zero point five seven eight New progress
      China Construction Bank Co., Ltd zero point five two five New progress
      Industrial and Commercial Bank of China shares zero point four six seven New progress
      Xu Long zero point four three one New progress

      Shareholding ratio of circulating shareholders



      user name:
      Password: